An Initiative of AVAC

South Korea

A snapshot of PrEP scale-up, registration and resources for South Korea.

  • N/A
    Estimated Number of Current PrEP Users

    Aggregates numbers reported from demonstration projects, PEPFAR dashboard and program/country reports where available. This is presented as a range due to difficulty in tracking precise numbers and possible double reporting.

  • N/A
    Aggregate Target Number of PrEP Users from All Projects (Planned & Ongoing)

    Sum of the targets available at the quarterly data review. National targets put forward by governments may be aspirational and/or indicative of estimated need; or they may be low or non-existent if PrEP is solely available via demonstration projects. For this reason, a calculation of current PrEP users as a percentage of aggregate target will not accurately reflect progress. Additionally, some programs set targets on an annual basis while targets from other programs may extend over multiple years.

Data Updated: July 31, 2018

Drug Registration Status

  • Gilead's Truvada (TDF/FTC) registration
    Approved
  • Generic versions of TDF/FTC for prevention
    Not submitted

Resources for South Korea

  • A Framework for Scaling Up PrEP can help implementers, government and advocates begin planning for and implementing PrEP programs.
  • Click here for the latest information from the South Korea Ministry of Health & Welfare.
  • APCOM is a coalition governments, United Nations agencies, non-profit organisations and community based organisations from Asia and the Pacific, working together to address HIV issues that affect the lives of men who have sex with men and transgender people. Click here to access PrEPMAP, their new guide to accessing PrEP in the region.